Connective Tissue Clinical Trials

59 recruitingLast updated: July 25, 2026

There are 59 actively recruiting connective tissue clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4, Phase 3, Early Phase 1. Top locations include New York, New York, United States, New Haven, Connecticut, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Connective Tissue Trials at a Glance

59 actively recruiting trials for connective tissue are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in New York, New Haven, and Beijing. Lead sponsors running connective tissue studies include Institute of Hematology & Blood Diseases Hospital, China, Hospital de Granollers, and University of Bern.

Browse connective tissue trials by phase

Treatments under study

About Connective Tissue Clinical Trials

Looking for clinical trials for Connective Tissue? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Connective Tissue trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Connective Tissue clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 59 trials

Recruiting
Not Applicable

Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

Rheumatoid ArthritisPsoriatic ArthritisSystemic Lupus Erythematosus+6 more
Terry L. Wahls400 enrolled1 locationNCT07180537
Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting
Not Applicable

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Fibrotic interstitial lung diseaseInterstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers92 enrolled1 locationNCT07482917
Recruiting
Not Applicable

Developing a Nutritional Supplement to Increase Collagen Synthesis in People

ExerciseDietary SupplementsConnective Tissue
University of California, Davis20 enrolled1 locationNCT06138106
Recruiting
Not Applicable

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

Cardiac conditionsCancerConnective Tissue Diseases+4 more
Unity Health Toronto170 enrolled3 locationsNCT06455384
Recruiting
Not Applicable

Evaluation of Multilayered PRF in Comparison With Connective Tissue Graft by Sohn Poncho's Technique on Peri-implant Mucosal Enhancement in the Esthetic Zone

Peri-implant healthSoft TissuePRF+2 more
Gulf Medical University26 enrolled1 locationNCT07649239
Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

SarcoidosisIdiopathic Pulmonary FibrosisInterstitial Lung Diseases+1 more
University of Chicago4,000 enrolled1 locationNCT00470327
Recruiting
Not Applicable

Volumetric Dimensional Changes After Surgical Pontic Site Development Procedures With Connective Tissue Graft or Collagen Matrix

Connective Tissue GraftVolume Collagen Matrix Xenograft
University of Bern38 enrolled1 locationNCT06335628
Recruiting

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease
Vanderbilt University Medical Center75 enrolled1 locationNCT05462574
Recruiting
Phase 1Phase 2

ADSCs Therapy in Patients With CTD-ILD

Interstitial Lung DiseaseConnective Tissue Diseases
China Medical University Hospital16 enrolled1 locationNCT06574581
Recruiting
Phase 2

Intralesional Injection of STS in Treatment of Calcinosis

DermatomyositisSystemic Sclerosis (SSc)Mixed Connective Tissue Disease (MCTD)+1 more
Robyn T. Domsic, MD, MPH20 enrolled1 locationNCT06672822
Recruiting
Not Applicable

Pontic Site Development With or Without Fixed Partial Denture

Connective Tissue GraftKeratinized Tissue DeficiencyMucogingival Defects+1 more
Cairo University20 enrolled1 locationNCT07535060
Recruiting
Not Applicable

Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases

Interstitial Lung DiseaseConnective Tissue Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS200 enrolled1 locationNCT07541638
Recruiting
Not Applicable

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Progressive Pulmonary FibrosisFibrotic interstitial lung diseaseInterstitial Lung Disease (ILD)+2 more
Hospital de Granollers152 enrolled1 locationNCT07486206
Recruiting
Phase 2

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+7 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Early Phase 1

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Systemic Lupus Erythematosus (SLE)Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT07490041
Recruiting
Not Applicable

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

Interstitial Lung DiseaseConnective Tissue Diseases
University Hospital, Bordeaux48 enrolled1 locationNCT07283081
Recruiting
Not Applicable

Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease

Undifferentiated Connective Tissue Diseases
CHU de Quebec-Universite Laval40 enrolled1 locationNCT06399822
Recruiting

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

Pulmonary HypertensionConnective Tissue DiseaseAdult Congenital Heart Disease+1 more
Children's Hospital Medical Center, Cincinnati5,000 enrolled1 locationNCT07477197
Recruiting
Phase 2

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Non-small Cell Lung CancerNSCLCNSCLC Stage II+5 more
Memorial Sloan Kettering Cancer Center25 enrolled7 locationsNCT07323732